Results 191 to 198 of about 5,026 (198)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment

Frontiers in Immunology, 2018
Diana Cadena Castañeda, Laurie Lajoie, Christophe Arnoult   +2 more
exaly  

FcRn-Inhibitor reduziert das Risiko für einen erneuten Krankheitsschub

InFo Neurologie + Psychiatrie
openaire   +1 more source

Response to comment on: “Emergent role of complement inhibitors in myasthenic crisis – Complement for crisis, FcRn for continuity (CNN-D-25–2177)”

Clinical Neurology and Neurosurgery
Rossini, Elena, Morino, Stefania, Garibaldi, Matteo, Leonardi, Luca, Tufano, Laura, Lauletta, Antonio, Forcina, Francesca, Antonini, Giovanni, Fionda, Laura   +8 more
openaire   +2 more sources

Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn

Proceedings of the National Academy of Sciences of the United States of America, 2008
exaly  

Faculty Opinions recommendation of The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2018
openaire   +1 more source

Effect of Applying Inclusion and Exclusion Criteria of Phase III Complement Inhibitor and FCRN Inhibitor Trials to Acetylcholine Receptor-positive Generalized Myasthenia Gravis Patients in Routine Clinical Care (P10-11.014)

Neurology
Nakul Katyal, Katherine Clifford, Martavius Lovall, Neelam Goyal, Srikanth Muppidi   +4 more
openaire   +1 more source

EE147 Complement C5 Inhibitor (Anti-C5) and Neonatal Fc Receptor Antagonist Anti-FcRn in Myasthenia Gravis at University Public Hospitals of Paris, France (AP-HP): What Is the Market Share of These New Treatments?

Value in Health
Nawel KASBADJI, ISABELLE FUSIER, ALBANE DEGRASSAT THEAS, Philippe Mougenot, Pascal Paubel   +4 more
openaire   +1 more source

Erratum for the Research Article: “The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study” by P. Kiessling, R. Lledo-Garcia, S. Watanabe, G. Langdon, D. Tran, M. Bari, L. Christodoulou, E. Jones, G. Price, B. Smith, F. Brennan, I. White, S. Jolles

Science Translational Medicine, 2017
openaire   +2 more sources